James M. Inhofe Bought Crispr Therapeutics AG (NASDAQ: CRSP) — Congressional Trade
James M. Inhofe (R-OK), a U.S. Senator, bought $15,001 - $50,000 of Crispr Therapeutics AG (NASDAQ: CRSP) on . Since the trade, CRSP is up +174.54% versus the S&P 500 up +236.73% — an outperformance of -62.19%.
Post-trade price performance
Crispr Therapeutics AG (NASDAQ: CRSP) vs the S&P 500 since James M. Inhofe bought on the disclosed date
Performance since trade
Price change since trade
+174.54%
S&P 500 change since trade
+236.73%
Outperformance vs S&P 500
-62.19%
Trade summary
James M. Inhofe (R-OK), a U.S. Senator, bought $15,001 - $50,000 of Crispr Therapeutics AG (NASDAQ: CRSP) on . Since the trade, CRSP is up +174.54% versus the S&P 500 up +236.73% — an outperformance of -62.19%.
- Entry price
- $18.97
- Latest price
- $52.08
- CRSP return
- +174.54%
- S&P 500 return
- +236.73%